EBSAM
TNDM icon

Eubel Brady & Suttman Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Eubel Brady & Suttman Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10
Closed -$1K – 315
2021
Q2 		$1K Buy
+10
New +$892 ﹤0.01% 638

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Eubel Brady & Suttman Asset Management's TNDM Position: Q3 2021 in Review

Eubel Brady & Suttman Asset Management sold out of Tandem Diabetes Care (TNDM) in Q3 2021, closing a stake of 10 shares — an estimated $1K sold.

Eubel Brady & Suttman Asset Management first reported a position in TNDM in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 337 funds tracked by Wall St. Rank hold TNDM as of Q3 2021.

  • Eubel Brady & Suttman Asset Management reported no remaining Tandem Diabetes Care position as of Q3 2021 after selling out during the quarter.
  • Eubel Brady & Suttman Asset Management sold 10 Tandem Diabetes Care shares in Q3 2021, an estimated $1K.
  • Eubel Brady & Suttman Asset Management first reported a position in Tandem Diabetes Care in Q2 2021 and held it in 1 quarter.
  • Eubel Brady & Suttman Asset Management's Tandem Diabetes Care position peaked at $1K in Q2 2021.
  • 337 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2021.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q3 2021, filed 5 Nov 2021.